Organon & Co. (OGN)
7.175
-0.18
(-2.51%)
USD |
NYSE |
Dec 12, 16:00
7.18
0.00 (0.00%)
After-Hours: 17:08
Organon Shareholders Equity (Quarterly): 906.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 51.85B |
| Amgen, Inc. | 9.619B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Rockwell Medical, Inc. | 37.02M |
| United Therapeutics Corp. | 6.590B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.55B |
| Total Liabilities (Quarterly) | 12.65B |
| Debt to Equity Ratio | 9.744 |
| Current Ratio | 1.754 |
| Net Debt Paydown Yield | -1.24% |